3rd Quarter - Report

VIATRIS INC. for VIATRIS INC

Period 3rd Quarter 2011 Filed Oct 20, 2011 Signed by Lara Ramsburg, VP Government Relations

Official filing
Firm
VIATRIS INC.
Client
VIATRIS INC
Income
—
Expenses
$290,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trade Agreements TPP, ACTA general trade issues

LobbyistCovered position, as disclosed
LEAH SUMMERS New —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

S.1356 Medicaid

LobbyistCovered position, as disclosed
BRUCE LOTT New —
LARA RAMSBURG New —

Contacted: U.S. Trade Representative (USTR); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 1356 (112th)

Copyright/Patent/Trademark CPT

Patent settlements and patent reform legislation

LobbyistCovered position, as disclosed
LARA RAMSBURG New —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Health Issues HCR

Authorized Generics, User Fees, Affordable Medicines Act, HR1249 The America Invents Act, Drug Safety, Drug Shortage, Food, Drug and Cosmetic Act, FDA, Issues related to Generic Drug Industry, Issues related to funding for Antiretrovirals (ARVs), PEPFAR, Global Fund, Serialization, Biosimilars

LobbyistCovered position, as disclosed
BRUCE LOTT New —
LARA RAMSBURG New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR)

Bills named: H.R. 1249 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.